ZS Pharma is named finalist for national award recognizing accelerator clients

The Dallas Morning News
By Hanah Cho
hcho@dallasnews.com
2:14 pm on March 4, 2013 | Permalink

ZS Pharma, a client of technology incubator TECH Fort Worth, is one of two finalists for the National Business Incubation Association‘s 2013 Outstanding Incubator Client award.

Darlene Ryan, TECH Fort Worth’s executive director, said the competition was stiff as the award sought finalists from clients of technology incubators in the U.S. and abroad.

ZS Pharma develops proprietary oral sorbent technology that removes toxins in patients suffering from kidney and liver disease.

The company joined TECH Worth in 2009. It received $2 million in funding from the Texas Emerging Technology Fund and recently raised $46 million in venture financing.

The winner will be announced April 9.